Synapse - Susan Prockop

Results (51)

Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation

Journal Article

Prockop, S.; Doubrovina, E.; Suser, S.; Heller, G.; Barker, J.; Dahi, P.; Perales, M. A.; Papadopoulos, E.; Sauter, C.; Castro-Malaspina, H.; more...
Journal of Clinical Investigation (2020)

Fulltext@MSK | Save

Allogeneic CD34-selected HSCT following CAR T-cells is associated with low TRM and favorable OS in pediatric/young adult patients with relapsed/refractory B-ALL

Meeting Abstract

Fabrizio, V.; Boulad, F.; Cancio, M. I.; Higman, M. A.; Margossian, S. P.; Mauguen, A.; Prockop, S.; Scaradavou, A.; Shah, N. C.; Spitzer, B.; more...
Blood (2019)

Fulltext@MSK | Save

Predictors of donor/host (D/H) lineage specific chimerism trends in pediatric patients following allogeneic hematopoietic cell transplantation

Meeting Abstract

Boulad, F.; Nicoletti, E.; Prockop, S. E.; Hsu, S.; Fuller, K.; Mauguen, A.; Kernan, N. A.; Scaradavou, A.; O'Reilly, R. J.; Boelens, J. J.
Biology of Blood and Marrow Transplantation (2019)

Fulltext@MSK | Save

Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL

Journal Article

Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Williams, D. A.; Shukla, N.; Kobos, R.; Forlenza, C. J.; Steinherz, P.; Prockop, S.; more...
Blood (2019)

Fulltext@MSK | Save

CAR T-cells followed by CD34-selected T-cell depleted (TCD) ALLO-HSCT is associated with low toxicity and favorable overall survival

Meeting Abstract

Fabrizio, V.; Boulad, F.; Cancio, M.; Margossian, S.; Mauguen, A.; Prockop, S.; Scaradavou, M.; Shah, N.; Spitzer, B.; Stieglitz, E.; more...
Pediatric Blood and Cancer (2019)

Fulltext@MSK | Save

Lineage specific chimerism analysis in pediatric patients following allogeneic hematopoietic cell transplantation (HCT). Influence of age, disease, cytoreduction, graft source and GVHD prophylaxis

Meeting Abstract

Boulad, F.; Nicoletti, E.; Prockop, S. E.; Hsu, S.; Fuller, K.; Mauguen, A.; Kernan, N. A.; Scaradavou, A.; O'Reilly, R. J.; Boelens, J. J.
Bone Marrow Transplantation (2019)

Fulltext@MSK | Save

Comparison of two T-cell depletion methods of grafts from alternative donors for allogeneic hematopoietic cell transplantation of patients with Fanconi anemia

Meeting Abstract

Boulad, F.; Avecilla, S. T.; Prockop, S.; Klein, E.; Mauguen, A.; Olechnowicz, J.; Cancio, M.; Boelens, J. J.; O'Reilly, R. J.
Cytotherapy (2019)

Fulltext@MSK | Save

Analysis of cytomegalovirus (CMV) infections in the first 180 days in adult sero-positive cord blood transplantation (CBT) recipients reveals high infection rates and treatment burden

Meeting Abstract

Lau, C.; Politikos, I.; Devlin, S. M.; Jacob, A. G.; Maloy, M.; Naputo, K.; Afuye, A.; Bhatt, V.; Dahi, P. B.; Perales, M. A.; more...
Biology of Blood and Marrow Transplantation (2018)

Fulltext@MSK | Save

Ex vivo CD34(+)–selected T cell–depleted peripheral blood stem cell grafts for allogeneic hematopoietic stem cell transplantation in acute leukemia and myelodysplastic syndrome is associated with low incidence of acute and chronic graft-versus-host disease and high treatment response